Barbituric acid derivatives as inhibitors of TNF-alpha converting enzyme (TACE) and/or matrix metalloproteinases
申请人:——
公开号:US20030229084A1
公开(公告)日:2003-12-11
The present application describes novel barbituric acid derivatives of formula I:
1
or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, B, L, R
1
, R
2
, R
3
, R
4
, R
5
, n, W, U, X, Y, Z, U
a
, X
a
, Y
a
, and Z
a
are defined in the present specification, which are useful as TNF-&agr; converting enzyme (TACE) and matrix metalloproteinases (MMP) inhibitors.
本申请描述了式I的新型巴比妥酸衍生物:
1
或其药用可接受的盐或前药形式,其中A、B、L、R
1
、R
2
、R
3
、R
4
、R
5
、n、W、U、X、Y、Z、U
a
、X
a
、Y
a
和Z
a
在本规范中定义,这些衍生物可用作TNF-α转化酶(TACE)和基质金属蛋白酶(MMP)抑制剂。